InvestorsHub Logo

flipper44

09/15/23 3:31 PM

#631265 RE: Baxers #631264

Great news! Thanks Baxers.

The Danish Dude

09/15/23 3:33 PM

#631267 RE: Baxers #631264

Are everyone aware of how huge this it?

Geez!

Thank for this!!!!!!
Bullish
Bullish

maverick_1

09/15/23 3:37 PM

#631269 RE: Baxers #631264





AND since December 2022 Red Right Hand LED this procession along with ATLnsder

FACT vs a decade of Elitists Flip Flopping with DEVASTATION period.

Hi profile prolific posters ONLY post & WITHOUT attribution AFTER it has been established!!!
Bullish
Bullish

supersteve13

09/15/23 3:40 PM

#631271 RE: Baxers #631264

Notice the footnotes for the section “ Generation of autologous dendritic cell vaccines.Monocyte-derived DCs were established from adherent peripheral blood mononuclear cells (PBMC) obtained via leukapheresis performed at the UCLA Hemapheresis Unit, as we have published on previously” include the NWBO JAMA oncology paper (ref 6). :)

DrHigh

09/15/23 3:49 PM

#631272 RE: Baxers #631264

might this be the final piece of the puzzle that will get this damn application submitted????

j e d

09/15/23 4:20 PM

#631284 RE: Baxers #631264

uh isn’t this massive?

exwannabe

09/15/23 4:47 PM

#631288 RE: Baxers #631264

Thanks for the link to the PolyICLI combo trial paper.

mOS for DC + Poly-ICLC in GBM patients was a whopping 13 months. [Figure 3B].

The long term survivors were 4 non GBM patients.

Thanks!

OH, and the PolyICLC arm was 44% IDH mutant.

vator

09/16/23 6:11 AM

#631387 RE: Baxers #631264

If they are not on major media outlets following peer review then shame on management. They could then talk about how the platform is intended for all cancer. It is done all the time with other one product companies. It would start getting us out of our hole and attract institutional interest with this visibility.

vator

09/16/23 6:19 AM

#631390 RE: Baxers #631264

This article for peer review is probably why Al M. Had to take the data down from his website.